Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day
Mural Oncology a clinical-stage oncology company focused on discovering and developing immunotherapies, held its first ...
Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival
The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not ...
NexCAR19 Marks A New Era: Exploring Promising Cancer Research And The Challenges Of Pre-Clinical Trials
We interviewed Sangeeta Shukla, Ph. D., a Bioinformatics Scientist for the Children’s Hospital of Philadelphia. We asked her ...
Asia One7h
Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer ...
This Early-Stage Breast Cancer Drug Will Be Widely Available, Thanks to a Clinical Trial
The FDA has expanded its approval of Kisqali, a drug already approved to treat advanced breast cancer, to include women with ...
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
FDA confirms that SciSparc’s study may proceedonly a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
FDA has lifted the clinical hold on Biomea Fusion's BMF-219 trials for type 1 and type 2 diabetes following a safety review, ...
Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer
People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both ...
Business Wire7d
Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain
Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...
Business Wire12d
CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027 - Over 80 Drugs In Clinical Trials - ResearchAndMarkets.com
The "CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027" report has been added to ResearchAndMarkets.com's offering. CD137, also known as 4-1BB, has emerged as a promising target for ...